Title of article
Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study)
Author/Authors
Meinertz، نويسنده , , Thomas and Lip، نويسنده , , Gregory Y.H and Lombardi، نويسنده , , Fedrico and Sadowski، نويسنده , , Zigmunt P and Kalsch، نويسنده , , Brigitte and Camez، نويسنده , , Anne and Hewkin، نويسنده , , Ann and Eberle، نويسنده , , Siegfried، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2002
Pages
7
From page
1300
To page
1306
Abstract
We report a double-blind, multicenter, multinational, placebo-controlled, and well-controlled trial to prove that the sustained-release (SR) formulation of propafenone is superior to placebo in preventing symptoms of paroxysmal atrial fibrillation (AF). A
Journal title
American Journal of Cardiology
Serial Year
2002
Journal title
American Journal of Cardiology
Record number
1894955
Link To Document